DOCSLIB.ORG

Diagnosis and Management of Primary Amenorrhea and Female Delayed Puberty

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

6 184 S Seppä and others Primary amenorrhea 184:6 R225–R242 Review MANAGEMENT OF ENDOCRINE DISEASE Diagnosis and management of primary amenorrhea and female delayed puberty Satu Seppä1,2 , Tanja Kuiri-Hänninen 1, Elina Holopainen3 and Raimo Voutilainen 1 Correspondence 1Departments of Pediatrics, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland, should be addressed 2Department of Pediatrics, Kymenlaakso Central Hospital, Kotka, Finland, and 3Department of Obstetrics and to R Voutilainen Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland Email [email protected] Abstract Puberty is the period of transition from childhood to adulthood characterized by the attainment of adult height and body composition, accrual of bone strength and the acquisition of secondary sexual characteristics, psychosocial maturation and reproductive capacity. In girls, menarche is a late marker of puberty. Primary amenorrhea is defined as the absence of menarche in ≥ 15-year-old females with developed secondary sexual characteristics and normal growth or in ≥13-year-old females without signs of pubertal development. Furthermore, evaluation for primary amenorrhea should be considered in the absence of menarche 3 years after thelarche (start of breast development) or 5 years after thelarche, if that occurred before the age of 10 years. A variety of disorders in the hypothalamus– pituitary–ovarian axis can lead to primary amenorrhea with delayed, arrested or normal pubertal development. Etiologies can be categorized as hypothalamic or pituitary disorders causing hypogonadotropic hypogonadism, gonadal disorders causing hypergonadotropic hypogonadism, disorders of other endocrine glands, and congenital utero–vaginal anomalies. This article gives a comprehensive review of the etiologies, diagnostics and management of primary amenorrhea from the perspective of pediatric endocrinologists and gynecologists. The goals of treatment vary European Journal of Endocrinology depending on both the etiology and the patient; with timely etiological diagnostics fertility may be attained even in those situations where no curable treatment exists. European Journal of Endocrinology (2021) 184, R225–R242 Invited Author’s profile Raimo Voutilainen is a pediatric endocrinologist and emeritus professor in pediatrics at the University of Eastern Finland and Kuopio University Hospital in Kuopio, Finland. His research fields have included both translational and clinical studies on adrenal and gonadal function during fetal, childhood and adult life. Adrenal tumors, congenital adrenal hyperplasia, premature adrenarche, pubertal development, and later health consequences of small and large birth size, and maternal pre-eclampsia have been his clinical research areas. Hair steroids and their relationship to cardiovascular disease risk is one of his current research interests. https://eje.bioscientifica.com © 2021 European Society of Endocrinology Published by Bioscientifica Ltd. https://doi.org/10.1530/EJE-20-1487 Printed in Great Britain Downloaded from Bioscientifica.com at 09/25/2021 04:20:59PM via free access -20-1487 Review S Seppä and others Primary amenorrhea 184:6 R226 Normal puberty and pubertal markers spurt, feminine adipose tissue distribution and accrual of bone strength. The endometrium proliferates and Puberty is the period of transition from childhood to eventually bleeds marking menarche. During the first adulthood characterized by the attainment of adult postmenarcheal years, about half of the cycles may be height and body composition, accrual of bone strength anovulatory and irregular menstruation may continue for and the acquisition of secondary sexual characteristics, several years after menarche. The gradual maturation of psychosocial maturation and reproductive capacity. Its the hypothalamic neuronal circuits by estrogens results biological control is complex involving multiple endocrine in generation of the GnRH and LH surge that induces systems that interact in an ordered, progressive pattern ovulation and regular menstrual cycles (4). beginning already in fetal life (1). During the first postnatal months, the human infant experiences a transient activation of the hypothalamic–pituitary–gonadal (HPG) Pubertal markers and timing axis described as minipuberty (2). Subsequently, the In girls, the first physical marker of puberty is thelarche, HPG axis is inactive until the beginning of puberty. The that is the transition from Tanner breast stage B1 precise mechanisms underlying the reactivation of the (prepubertal stage) to B2 (glandular breast tissue) (1, HPG axis are not fully known. Although they are strongly 5, 6). Development of pubic hair, pubarche, is usually determined by genetics, also environmental, nutritional not regarded as a sign of pubertal onset because it may and stress-related factors play a role (1, 3). result from adrenarche being independent of HPG axis Reactivation of the HPG axis is characterized by a activation. Adrenarche refers to the morphological gradual increase in hypothalamic gonadotropin-releasing and functional development of the zona reticularis in hormone (GnRH) secretion. Episodic GnRH boluses the adrenal cortex resulting in increased production are secreted into the hypothalamic–pituitary–portal of adrenal androgen precursors in mid-childhood. It is system to reach the anterior pituitary gland, where they associated with secondary sexual characteristics such as stimulate the secretion of gonadotropins luteinizing the development of pubic and axillary hair, acne and hormone (LH) and follicle-stimulating hormone (FSH) in adult type body odor. Adrenarche may precede, overlap a progressive fashion (1) (Fig. 1). LH stimulates ovarian or follow gonadarche with a wide variation in timing, follicular theca cells to produce androgens, which are clinical signs and adrenal androgen secretion (reviewed converted to estrogens in granulosa cells by FSH-induced in (7)). Menarche is regarded as a late marker of puberty aromatase. Increasing estrogen levels in girls result in in girls (6). Typically, it occurs within 2 to 3 years after European Journal of Endocrinology gradual breast tissue and uterine growth, pubertal growth thelarche at Tanner stage IV of breast development (5, 8, 9). It is rare before Tanner stage III of breast development Secondary sexual characteristics (5). Pubertal development is completed approximately 1.5 years after menarche (reviewed in (10)). Hypothalamus Pubertal timing varies in the population, and 50 to Follicular + phase Breast Comedones 80% of this variation is genetically determined (1, 3, 10). development Luteal - In most populations, 95% of girls experience the onset of phase GnRH Axillary hair Adult type body odor puberty between 8.5 and 13 years of age (1). However, a Adrenarche downward secular trend in the onset of breast development Pituitary Follicular phase + Pubic hair has been reported (8, 11, 12). According to a recent meta- Changes in LH, FSH body composition analysis, the age at pubertal onset based on thelarche had Luteal - phase Growth spurt decreased by almost 3 months per decade from 1977 to Ovary 2013 (12). The average age of menarche has decreased significantly between the 19th and the mid-20th centuries estrogen, progesterone in many countries, due to improved general health, nutrition and lifestyle (reviewed in (1, 10)). After that, the Figure 1 median age at menarche has remained more stable across Hypothalamus–pituitary–ovarian (HPO) axis and secondary well-nourished populations in developed countries (11, sexual characteristics. FSH, follicle-stimulating hormone; 13, 14, 15), although a small but statistically significant GnRH, gonadotropin-stimulating hormone; LH, luteinizing decline has been reported (11, 16). A large study from the hormone. United States reported the median age at menarche to be https://eje.bioscientifica.com Downloaded from Bioscientifica.com at 09/25/2021 04:20:59PM via free access Review S Seppä and others Primary amenorrhea 184:6 R227 12.43 years (14). In that study, menarche was significantly fractures, history or symptoms of chronic diseases, earlier in non-Hispanic black girls compared with non- psychosocial functioning and the intensity of exercise. Hispanic white and Mexican–American girls. In a large If pubertal development is delayed or stalled, a complete Danish study, estimated age at menarche was 13.42 years family history, including childhood growth patterns, in 1991 and 13.13 years in 2006 (11). age at pubertal onset of both parents and siblings, age of menarche of the close relatives, and any history of infertility, anosmia, midline abnormalities and chronic Definition of primary amenorrhea diseases should be included. Timing of possible breast and pubic hair development should be reviewed. A full physical Primary amenorrhea is defined as the absence of menarche examination is needed to consider the broad spectrum of in ≥15-year-old females with developed secondary sexual differential diagnoses. Normal breast development and characteristics and normal growth or in ≥13-year-old presence of secondary sexual characteristics indicate that females without signs of pubertal development (i.e. circulating estrogens are or at least have been present. delayed puberty) (Fig. 1) (13, 17). Furthermore, evaluation In most cases, the external gynecological examination of primary amenorrhea should be initiated 3 years post- with abdominal ultrasonography is sufficient to evaluate thelarche
Recommended publications
  • Premature Ovarian Insufficiency

    Premature Ovarian Insufficiency

    biomedicines Review Premature Ovarian Insufficiency: Procreative Management and Preventive Strategies Jennifer J. Chae-Kim 1 and Larisa Gavrilova-Jordan 2,* 1 Department of Obstetrics and Gynecology, East Carolina University, Greenville, NC 27834, USA; [email protected] 2 Department of Obstetrics and Gynecology, Augusta University, Augusta, GA 30912, USA * Correspondence: [email protected]; Tel.: +1-706-721-3832 Received: 30 November 2018; Accepted: 24 December 2018; Published: 28 December 2018 Abstract: Premature ovarian insufficiency (POI) is the loss of normal hormonal and reproductive function of ovaries in women before age 40 as the result of premature depletion of oocytes. The incidence of POI increases with age in reproductive-aged women, and it is highest in women by the age of 40 years. Reproductive function and the ability to have children is a defining factor in quality of life for many women. There are several methods of fertility preservation available to women with POI. Procreative management and preventive strategies for women with or at risk for POI are reviewed. Keywords: premature ovarian insufficiency; in vitro fertilization; donor oocyte; fertility preservation 1. Introduction Premature ovarian insufficiency (POI) is the loss of normal hormonal and reproductive function of ovaries in women before age 40 as the result of premature depletion of oocytes. POI is characterized by elevated gonadotrophin levels, hypoestrogenism, and amenorrhea, occurring years before the average age of menopause. Previously referred to as ovarian failure or early menopause, POI is now understood to be a condition that encompasses a range of impaired ovarian function, with clinical implications overlapping but not synonymous to that of physiologic menopause.
  • Successful Uterovaginal Anastomosis in an Unusual Presentation Of

    Successful Uterovaginal Anastomosis in an Unusual Presentation Of

    JSAFOMS Successful Uterovaginal Anastomosis in an Unusual Presentation10.5005/jp-journals-10032-1056 of Congenital Absence of Cervix CASE REPORT Successful Uterovaginal Anastomosis in an Unusual Presentation of Congenital Absence of Cervix 1Nusrat Mahmud, 2Naushaba Tarannum Mahtab, 3TA Chowdhury, 4Anjan Kumar Deb ABSTRACT Source of support: Nil Cervical agenesis or dysgenesis (fragmentation, fibrous cord Conflict of interest: None and obstruction) is an extremely rare congenital anomaly. Conser vative surgical approach to these patients involves uterovaginal anastomosis, cervical canalization and cervical INTRODUCTION reconstruction. In failed conservative surgery, total hysterec- Primary amenorrhea is defined as absence of menstrua- tomy is the treatment of choice. We report what we believe to be the first successful end-to-end uterovaginal anastomosis of tion by the age of 14 years in the absence of secondary an unusual case of congenital cervical agenesis. A 25-year- sex characteristics or the absence of periods by the age of old female presented complaining of primary amenorrhea 16 years regardless of appearance of secondary sex and primary subfertility for the same duration. At laparoscopy, complete separation between the cervix and the body of the charac ters. In our last study, a series of total 108 cases uterus was found and hanging from surrounding supports. of primary amenorrhea were reviewed. It was found Both ovaries and fallopian tubes were anatomically positioned. that 69.4% were due Müllerian dysgenesis, 19.4% due to There was another muscular tissue of 2 cm in diameter at the gonadal dysgenesis, 2.7% male pseudohermaphroditism pouch of Douglas which was attached with lateral pelvic wall 13 by transverse cervical ligament.
  • Androgen Excess in Breast Cancer Development: Implications for Prevention and Treatment

    Androgen Excess in Breast Cancer Development: Implications for Prevention and Treatment

    26 2 Endocrine-Related G Secreto et al. Androgen excess in breast 26:2 R81–R94 Cancer cancer development REVIEW Androgen excess in breast cancer development: implications for prevention and treatment Giorgio Secreto1, Alessandro Girombelli2 and Vittorio Krogh1 1Epidemiology and Prevention Unit, Fondazione IRCCS – Istituto Nazionale dei Tumori, Milano, Italy 2Anesthesia and Critical Care Medicine, ASST – Grande Ospedale Metropolitano Niguarda, Milano, Italy Correspondence should be addressed to G Secreto: [email protected] Abstract The aim of this review is to highlight the pivotal role of androgen excess in the Key Words development of breast cancer. Available evidence suggests that testosterone f breast cancer controls breast epithelial growth through a balanced interaction between its two f ER-positive active metabolites: cell proliferation is promoted by estradiol while it is inhibited by f ER-negative dihydrotestosterone. A chronic overproduction of testosterone (e.g. ovarian stromal f androgen/estrogen balance hyperplasia) results in an increased estrogen production and cell proliferation that f androgen excess are no longer counterbalanced by dihydrotestosterone. This shift in the androgen/ f testosterone estrogen balance partakes in the genesis of ER-positive tumors. The mammary gland f estradiol is a modified apocrine gland, a fact rarely considered in breast carcinogenesis. When f dihydrotestosterone stimulated by androgens, apocrine cells synthesize epidermal growth factor (EGF) that triggers the ErbB family receptors. These include the EGF receptor and the human epithelial growth factor 2, both well known for stimulating cellular proliferation. As a result, an excessive production of androgens is capable of directly stimulating growth in apocrine and apocrine-like tumors, a subset of ER-negative/AR-positive tumors.
  • Background Briefing Document from the Consortium of Sponsors for The

    Background Briefing Document from the Consortium of Sponsors for The

    BRIEFING BOOK FOR Pediatric Advisory Committee (PAC) Prepared by Alan Rogol, M.D., Ph.D. Prepared for Consortium of Sponsors Meeting Date: April 8th, 2019 TABLE OF CONTENTS LIST OF FIGURES ................................................... ERROR! BOOKMARK NOT DEFINED. LIST OF TABLES ...........................................................................................................................4 1. INTRODUCTION AND BACKGROUND FOR THE MEETING .............................6 1.1. INDICATION AND USAGE .......................................................................................6 2. SPONSOR CONSORTIUM PARTICIPANTS ............................................................6 2.1. TIMELINE FOR SPONSOR ENGAGEMENT FOR PEDIATRIC ADVISORY COMMITTEE (PAC): ............................................................................6 3. BACKGROUND AND RATIONALE .........................................................................7 3.1. INTRODUCTION ........................................................................................................7 3.2. PHYSICAL CHANGES OF PUBERTY ......................................................................7 3.2.1. Boys ..............................................................................................................................7 3.2.2. Growth and Pubertal Development ..............................................................................8 3.3. AGE AT ONSET OF PUBERTY.................................................................................9 3.4.
  • Human Physiology/The Male Reproductive System 1 Human Physiology/The Male Reproductive System

    Human Physiology/The Male Reproductive System 1 Human Physiology/The Male Reproductive System

    Human Physiology/The male reproductive system 1 Human Physiology/The male reproductive system ← The endocrine system — Human Physiology — The female reproductive system → Homeostasis — Cells — Integumentary — Nervous — Senses — Muscular — Blood — Cardiovascular — Immune — Urinary — Respiratory — Gastrointestinal — Nutrition — Endocrine — Reproduction (male) — Reproduction (female) — Pregnancy — Genetics — Development — Answers Introduction In simple terms, reproduction is the process by which organisms create descendants. This miracle is a characteristic that all living things have in common and sets them apart from nonliving things. But even though the reproductive system is essential to keeping a species alive, it is not essential to keeping an individual alive. In human reproduction, two kinds of sex cells or gametes are involved. Sperm, the male gamete, and an egg or ovum, the female gamete must meet in the female reproductive system to create a new individual. For reproduction to occur, both the female and male reproductive systems are essential. While both the female and male reproductive systems are involved with producing, nourishing and transporting either the egg or sperm, they are different in shape and structure. The male has reproductive organs, or genitals, that are both inside and outside the pelvis, while the female has reproductive organs entirely within the pelvis. The male reproductive system consists of the testes and a series of ducts and glands. Sperm are produced in the testes and are transported through the reproductive ducts. These ducts include the epididymis, ductus deferens, ejaculatory duct and urethra. The reproductive glands produce secretions that become part of semen, the fluid that is ejaculated from the urethra. These glands include the seminal vesicles, prostate gland, and bulbourethral glands.
  • Cervical and Vaginal Agenesis: a Novel Anomaly

    Cervical and Vaginal Agenesis: a Novel Anomaly

    Cervical and Vaginal Agenesis: A Novel Anomaly Case Report Cervical and Vaginal Agenesis: A Novel Anomaly Irum Sohail1, Maria Habib 2 1Professor Obs/Gynae, 2Postgraduate Trainee, Wah Medical College, Wah Cantt Address of Correspondence: Dr. Maria Habib, Postgraduate Trainee, Wah Medical College, Wah Cantt Email: [email protected] Abstract Background: Cervical agenesis with vaginal agenesis is an extremely rare congenital anomaly. This mullerian anomaly occurs in 1 in 80,000-100,000 births. It is classified as type IB in the American Fertility Society Classification of mullerian anomalies. Case report: We report a case presented to POF Hospital, Wah cantt with primary amenorrhea and cyclic lower abdominal pain. She was diagnosed to have cervical agenesis associated with completely absent vagina. Conservative surgical approach to these patients involve uterovaginal anastomosis and cervical reconstruction. Creation of neovagina is necessary in these cases. Due to high failure rate and potential for complications, total hysterectomy with vaginoplasty is the treatment of choice by many authors. Conclusion: A thorough investigation of the patients with primary amenorrhea is necessary and total hysterectomy with vaginoplasty is feasible and should be considered as a first-line treatment option in cases of cervical and vaginal agenesis. Key words: Primary amenorrhea, Cervical agenesis, Vaginal agenesis, Hysterectomy. Introduction The female reproductive organs develop from the Society of Human Reproduction and Embryology fusion of the bilateral paramesonephric (Müllerian) (ESHRE)/European Society for Gynaecological ducts to form the uterus, cervix, and upper two- Endoscopy (ESGE) classification system of female thirds of the vagina.1 The lower third of the vagina genital anomalies is designed for clinical orientation develops from the sinovaginal bulbs of the and it is based on the anatomy of the female urogenital sinus.2 Mullerian duct anomalies (MDAs) genital tract.
  • Genetic Syndromes and Genes Involved

    Genetic Syndromes and Genes Involved

    ndrom Sy es tic & e G n e e n G e f Connell et al., J Genet Syndr Gene Ther 2013, 4:2 T o Journal of Genetic Syndromes h l e a r n a DOI: 10.4172/2157-7412.1000127 r p u y o J & Gene Therapy ISSN: 2157-7412 Review Article Open Access Genetic Syndromes and Genes Involved in the Development of the Female Reproductive Tract: A Possible Role for Gene Therapy Connell MT1, Owen CM2 and Segars JH3* 1Department of Obstetrics and Gynecology, Truman Medical Center, Kansas City, Missouri 2Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 3Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA Abstract Müllerian and vaginal anomalies are congenital malformations of the female reproductive tract resulting from alterations in the normal developmental pathway of the uterus, cervix, fallopian tubes, and vagina. The most common of the Müllerian anomalies affect the uterus and may adversely impact reproductive outcomes highlighting the importance of gaining understanding of the genetic mechanisms that govern normal and abnormal development of the female reproductive tract. Modern molecular genetics with study of knock out animal models as well as several genetic syndromes featuring abnormalities of the female reproductive tract have identified candidate genes significant to this developmental pathway. Further emphasizing the importance of understanding female reproductive tract development, recent evidence has demonstrated expression of embryologically significant genes in the endometrium of adult mice and humans. This recent work suggests that these genes not only play a role in the proper structural development of the female reproductive tract but also may persist in adults to regulate proper function of the endometrium of the uterus.
  • Menstrual Disorders Susan Hayden Gray, MD* Practice Gap 1

    Menstrual Disorders Susan Hayden Gray, MD* Practice Gap 1

    Article genital system disorders Menstrual Disorders Susan Hayden Gray, MD* Practice Gap 1. Dysmenorrhea, amenorrhea, and abnormal vaginal bleeding affect the majority of Author Disclosure adolescent females, impacting quality of life and school attendance. Patient-centered Dr Gray has disclosed adolescent care should include searching for, assessing, and managing menstrual concerns. no financial 2. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in young relationships relevant adult women, and pediatricians should recognize, monitor, educate, and manage their to this article. This patients who fit the medical profile for PCOS based on any/all of the three sets of commentary does diagnostic criteria. contain a discussion of an unapproved/ Objectives After reading this article, readers should be able to: investigative use of a commercial product/ 1. Define primary and secondary amenorrhea and list the differential diagnosis for each. device. 2. Recognize the importance of a sensitive urine pregnancy test early in the evaluation of menstrual disorders, regardless of stated sexual history. 3. Know that polycystic ovary syndrome is a common cause of secondary amenorrhea in adolescents and may present with oligomenorrhea or abnormal uterine bleeding. 4. Recognize that eating disordered behaviors are a common cause of secondary amenorrhea and irregular bleeding, and treatment of the eating disordered behavior is the best recommendation to ensure resumption of regular menses and long-term bone health. 5. Know the differential diagnosis of abnormal uterine bleeding and describe the preferred treatment, recognizing the central importance of iron replacement. 6. Understand the prevalence of primary dysmenorrhea and its role in causing recurrent school absence in young women, and describe its evaluation and management.
  • Estrogen Deficiency During Menopause and Its Management: a Current Update V

    Estrogen Deficiency During Menopause and Its Management: a Current Update V

    Review Article Estrogen deficiency during menopause and its management: A current update V. T. Hemalatha1, A. Julius2, S. P. Kishore Kumar3, L. Vijayalakshmi4, Shankar Narayanan1 ABSTRACT Different phases of a woman’s life: Puberty, menses, pregnancy, and menopause have varied influence on her oral health. During the menopause, women go through biological and endocrine changes, particularly in their sex steroid hormone production, affecting their health. Sex hormones strongly influence body fat distribution and adipocyte differentiation. Estrogens and testosterone differentially affect adipocyte physiology, but the importance of estrogens in the development of metabolic diseases during menopause is disputed. Estrogens and estrogens receptor regulate various aspects of glucose and lipid metabolism. Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in woman. The absence of estrogens is a clue factor in the onset of cardiovascular disease during the menopausal period, which is characterized by lipid profile variations and predominant abdominal fat accumulation. However, influence of the absence of these hormones and its relationship to higher obesity in women during menopause is not clear. This systematic review discusses of the role of estrogens and estrogen receptors in adipocyte differentiation and its various effects and brief discussion on its management. KEY WORDS: Estrogen hormone (estrogens/progestogens) replacement therapy, Menopause, Weight gain INTRODUCTION BODY CHANGES AT MENOPAUSE Menopause occurs when a woman stops ovulating and As we age, our muscles decrease in bulk and our her monthly period (menstruation) stops. metabolism slows down. These changes cancontribute to weight gain around the time of menopause. Other As women age, into their 40s and 50s, there is a tendency physical changes associated with menopause may to gain weight.
  • Variability in the Length of Menstrual Cycles Within and Between Women - a Review of the Evidence Key Points

    Variability in the Length of Menstrual Cycles Within and Between Women - a Review of the Evidence Key Points

    Variability in the Length of Menstrual Cycles Within and Between Women - A Review of the Evidence Key Points • Mean cycle length ranges from 27.3 to 30.1 days between ages 20 and 40 years, follicular phase length is 13-15 days, and luteal phase length is less variable and averages 13-14 days1-3 • Menstrual cycle lengths vary most widely just after menarche and just before menopause primarily as cycles are anovulatory 1 • Mean length of follicular phase declines with age3,11 while luteal phase remains constant to menopause8 • The variability in menstrual cycle length is attributable to follicular phase length1,11 Introduction Follicular and luteal phase lengths Menstrual cycles are the re-occurring physiological – variability of menstrual cycle changes that happen in women of reproductive age. Menstrual cycles are counted from the first day of attributable to follicular phase menstrual flow and last until the day before the next onset of menses. It is generally assumed that the menstrual cycle lasts for 28 days, and this assumption Key Points is typically applied when dating pregnancy. However, there is variability between and within women with regard to the length of the menstrual cycle throughout • Follicular phase length averages 1,11,12 life. A woman who experiences variations of less than 8 13-15 days days between her longest and shortest cycle is considered normal. Irregular cycles are generally • Luteal phase length averages defined as having 8 to 20 days variation in length of 13-14 days1-3 cycle, whereas over 21 days variation in total cycle length is considered very irregular.
  • Hypogonadism in Adolescence 173:1 R15–R24 Review

    Hypogonadism in Adolescence 173:1 R15–R24 Review

    A A Dwyer and others Hypogonadism in adolescence 173:1 R15–R24 Review TRANSITION IN ENDOCRINOLOGY Hypogonadism in adolescence Andrew A Dwyer1,2, Franziska Phan-Hug1,3, Michael Hauschild1,3, Eglantine Elowe-Gruau1,3 and Nelly Pitteloud1,2,3,4 1Center for Endocrinology and Metabolism in Young Adults (CEMjA), 2Endocrinology, Diabetes and Metabolism Correspondence Service and 3Division of Pediatric Endocrinology Diabetology and Obesity, Department of Pediatric Medicine and should be addressed Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland and to N Pitteloud 4Department of Physiology, Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 7, Email 1005 Lausanne, Switzerland [email protected] Abstract Puberty is a remarkable developmental process with the activation of the hypothalamic–pituitary–gonadal axis culminating in reproductive capacity. It is accompanied by cognitive, psychological, emotional, and sociocultural changes. There is wide variation in the timing of pubertal onset, and this process is affected by genetic and environmental influences. Disrupted puberty (delayed or absent) leading to hypogonadism may be caused by congenital or acquired etiologies and can have significant impact on both physical and psychosocial well-being. While adolescence is a time of growing autonomy and independence, it is also a time of vulnerability and thus, the impact of hypogonadism can have lasting effects. This review highlights the various forms of hypogonadism in adolescence and the clinical challenges in differentiating normal variants of puberty from pathological states. In addition, hormonal treatment, concerns regarding fertility, emotional support, and effective transition to adult care are discussed. European Journal of Endocrinology (2015) 173, R15–R24 European Journal of Endocrinology Introduction Adolescence is generally defined as the transitional phase (FSH)) (1, 2).
  • From Adrenarche to Aging of Adrenal Zona Reticularis: Precocious Female Adrenopause Onset

    From Adrenarche to Aging of Adrenal Zona Reticularis: Precocious Female Adrenopause Onset

    ID: 20-0416 9 12 E Nunes-Souza et al. Precocious female 9:12 1212–1220 adrenopause onset RESEARCH From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset Emanuelle Nunes-Souza1,2,3, Mônica Evelise Silveira4, Monalisa Castilho Mendes1,2,3, Seigo Nagashima5,6, Caroline Busatta Vaz de Paula5,6, Guilherme Vieira Cavalcante da Silva5,6, Giovanna Silva Barbosa5,6, Julia Belgrowicz Martins1,2, Lúcia de Noronha5,6, Luana Lenzi7, José Renato Sales Barbosa1,3, Rayssa Danilow Fachin Donin3, Juliana Ferreira de Moura8, Gislaine Custódio2,4, Cleber Machado-Souza1,2,3, Enzo Lalli9 and Bonald Cavalcante de Figueiredo1,2,3,10 1Pelé Pequeno Príncipe Research Institute, Água Verde, Curitiba, Parana, Brazil 2Faculdades Pequeno Príncipe, Rebouças, Curitiba, Parana, Brazil 3Centro de Genética Molecular e Pesquisa do Câncer em Crianças (CEGEMPAC) at Universidade Federal do Paraná, Agostinho Leão Jr., Glória, Curitiba, Parana, Brazil 4Laboratório Central de Análises Clínicas, Hospital de Clínicas, Universidade Federal do Paraná, Centro, Curitiba, Paraná, Brazil 5Serviço de Anatomia Patológica, Hospital de Clínicas, Universidade Federal do Paraná, General Carneiro, Alto da Glória, Curitiba, Parana, Brazil 6Departamento de Medicina, PUC-PR, Prado Velho, Curitiba, Parana, Brazil 7Departamento de Análises Clínicas, Universidade Federal do Paraná, Curitiba, Paraná, Brazil 8Pós Graduação em Microbiologia, Parasitologia e Patologia, Departamento de Patologia Básica – UFPR, Curitiba, Brazil 9Institut de Pharmacologie Moléculaire et Cellulaire CNRS, Sophia Antipolis, Valbonne, France 100Departamento de Saúde Coletiva, Universidade Federal do Paraná, Curitiba, Paraná, Brazil Correspondence should be addressed to B C de Figueiredo: [email protected] Abstract Objective: Adaptive changes in DHEA and sulfated-DHEA (DHEAS) production from adrenal zona reticularis (ZR) have been observed in normal and pathological conditions.